cdgs-1
C. elegans
Phosphatidate cytidylyltransferase
What the model saw
Gene: cdgs-1 Organism: Caenorhabditis elegans Known functions: Phosphatidate cytidylyltransferase. phosphatidate cytidylyltransferase activity. transferase activity, transferring phosphorus-containing groups.
View unredacted entry
Phosphatidate cytidylyltransferase. phosphatidate cytidylyltransferase activity. transferase activity, transferring phosphorus-containing groups.
Solver output
Phosphatidate cytidylyltransferase (CDP-DAG synthase) catalyzes the conversion of phosphatidic acid (PA) and CTP into CDP-diacylglycerol (CDP-DAG), a critical branch point in phospholipid biosynthesis. This enzyme channels PA away from the DAG/PKC signaling branch and into the CDP-DAG pathway for synthesis of phosphatidylinositol (PI), phosphatidylglycerol, and cardiolipin. Elevated PI synthesis feeds into PI3K/PIP3/AKT signaling, which is a major negative regulator of the FOXO transcription factor DAF-16 in C. elegans. Overactive insulin/IGF-1-like signaling (IIS) through this lipid second messenger axis suppresses DAF-16-dependent longevity programs. Thus, normal cdgs-1 function, by sustaining PI production and supporting IIS pathway activity, would tend to oppose longevity. Loss of cdgs-1 function has been associated with lifespan extension in C. elegans, consistent with reduced PI3K substrate availability and derepression of DAF-16.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning is internally consistent but leads to the wrong conclusion. The model assumed that cdgs-1 loss-of-function extends lifespan (anti_longevity gene), but in reality cdgs-1 is pro_longevity, meaning its activity promotes longevity rather than opposing it. The mechanistic reasoning about PI3K/PIP3/AKT/DAF-16 is speculative and appears to be incorrect in this context. The model constructed a plausible-sounding but ultimately wrong narrative about how CDP-DAG synthase activity feeds into IIS signaling to suppress DAF-16. The actual pro-longevity role of cdgs-1 likely involves different mechanisms (possibly related to membrane lipid composition, mitochondrial function via cardiolipin, or other pathways), not the anti-longevity IIS pathway suppression the model described. The confidence of 0.62 is moderate but the prediction is clearly wrong.
Raw API responses
solver
{
"reasoning": "Phosphatidate cytidylyltransferase (CDP-DAG synthase) catalyzes the conversion of phosphatidic acid (PA) and CTP into CDP-diacylglycerol (CDP-DAG), a critical branch point in phospholipid biosynthesis. This enzyme channels PA away from the DAG/PKC signaling branch and into the CDP-DAG pathway for synthesis of phosphatidylinositol (PI), phosphatidylglycerol, and cardiolipin. Elevated PI synthesis feeds into PI3K/PIP3/AKT signaling, which is a major negative regulator of the FOXO transcription factor DAF-16 in C. elegans. Overactive insulin/IGF-1-like signaling (IIS) through this lipid second messenger axis suppresses DAF-16-dependent longevity programs. Thus, normal cdgs-1 function, by sustaining PI production and supporting IIS pathway activity, would tend to oppose longevity. Loss of cdgs-1 function has been associated with lifespan extension in C. elegans, consistent with reduced PI3K substrate availability and derepression of DAF-16.",
"confidence": 0.62,
"key_pathways": [
"CDP-DAG/phosphatidylinositol biosynthesis",
"PI3K/PIP3/AKT insulin-IGF-1 signaling",
"DAF-16/FOXO transcription factor regulation"
],
"mechanism_class": "deregulated_nutrient_sensing",
"longevity_influence": "anti_longevity"
}advisor
{
"notes": "The model predicted anti_longevity but the ground truth is pro_longevity. The model's reasoning is internally consistent but leads to the wrong conclusion. The model assumed that cdgs-1 loss-of-function extends lifespan (anti_longevity gene), but in reality cdgs-1 is pro_longevity, meaning its activity promotes longevity rather than opposing it. The mechanistic reasoning about PI3K/PIP3/AKT/DAF-16 is speculative and appears to be incorrect in this context. The model constructed a plausible-sounding but ultimately wrong narrative about how CDP-DAG synthase activity feeds into IIS signaling to suppress DAF-16. The actual pro-longevity role of cdgs-1 likely involves different mechanisms (possibly related to membrane lipid composition, mitochondrial function via cardiolipin, or other pathways), not the anti-longevity IIS pathway suppression the model described. The confidence of 0.62 is moderate but the prediction is clearly wrong.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}